Webinar: How to Supercharge Real World Evidence Generation in Phase IV Trials
Syneos Health joins Medable and Pluto Health to discuss patient-first digital trial solutions that transform RWD into actionable RWE insights.
For a fraction of the cost, digital trial solutions (e.g., eConsent, eCOA, TeleVisit, Connected Sensors) combined with Real World Data (RWD) can solve traditional Phase 4 trial challenges while capturing the critical endpoint data needed for long-term follow-up studies and informing future protocol designs and trial efficiencies.
In this webinar, Robert Zambon joins Medable and Pluto Health to discuss how they have partnered to deploy patient-first digital trial solutions that leverage RWD, transforming it into actionable RWE insights for a sponsor client.
Meet Our Speaker:
Robert Zambon
Vice President, Transformational Design, Solution Architecture & Strategy Partnerships
Syneos Health
Dr. Zambon is Vice President, Solution Design, at Syneos Health. In his role, Dr. Zambon leads and supports the development and operationalization of strategic solutions for Syneos Health’s clients to help address their key R&D and commercial needs by integrating data, technology, analytics, and various partnerships into approaches that accelerate and advance their most important development programs.
Dr. Zambon has over twenty years of experience in the life sciences industry with experience in data science, strategy development, clinical research, product development, sales force training, client management, regulatory affairs, analytics, and market research. He’s led and supported innovative research programs, including pragmatic, decentralized, and siteless studies, in the areas of cardiology, orthopedics, immunology, infectious disease, and various medical countermeasures.
Dr. Zambon received his Ph.D. in Molecular & Cell Biology at the University of Maryland and his B.S. in Biotechnology at Rutgers University.
